Increasing oral absorption of polar neuraminidase inhibitors: a prodrug transporter approach applied to oseltamivir analogue.
about
Carrier-Mediated Prodrug Uptake to Improve the Oral Bioavailability of Polar Drugs: An Application to an Oseltamivir AnalogueFrom neuraminidase inhibitors to conjugates: a step towards better anti-influenza drugs?Provisional in-silico biopharmaceutics classification (BCS) to guide oral drug product development.Experimental models for predicting drug absorption and metabolism.Rates and effectiveness of antiviral use among hospitalized influenza patients.Hydrotropic Solubilization of Lipophilic Drugs for Oral Delivery: The Effects of Urea and Nicotinamide on Carbamazepine Solubility-Permeability Interplay.Amino Acid Prodrugs: An Approach to Improve the Absorption of HIV-1 Protease Inhibitor, LopinavirParticle replication in nonwetting templates nanoparticles with tumor selective alkyl silyl ether docetaxel prodrug reduces toxicity.Biopharmaceutical Characterization of Nebulized Antimicrobial Agents in Rats: 5. Oseltamivir CarboxylateAdvanced Prodrug Strategies in Nucleoside and Non-Nucleoside Antiviral Agents: A Review of the Recent Five Years.In Silico Absorption Analysis of Valacyclovir in Wildtype and Pept1 Knockout Mice Following Oral Dose Escalation.Modern prodrug design for targeted oral drug delivery.Structural basis of malodour precursor transport in the human axillaThiodipeptides targeting the intestinal oligopeptide transporter as a general approach to improving oral drug delivery
P2860
Q28833485-B6A28930-FA8E-4E94-B63D-1CA87966A4C9Q30363724-DF1AEEC5-ADC5-4A6F-B903-6CFAA732571CQ34273688-957C67E8-0DFF-45D2-BE11-915CE43149F7Q38107970-756619CE-08C9-4E76-B576-733BBD84E9B4Q38476530-81C5CDAA-11E3-466E-86A4-E8DBC7856B1AQ39203327-CCB437E7-E2D2-4DB1-857F-F1C53FFD0DAFQ39395865-E2057030-24BF-4613-922A-FE5C0D69FD5FQ42109453-23CF567B-F454-4E58-8C95-86EECDB2D843Q42407634-EC2A7B62-6056-4EA7-874B-3C28C61B6453Q47611417-CC9FD882-8515-4DBE-95BF-6E17A6CAAF44Q50512905-85E41C96-0AC4-46A7-8710-970774AB044BQ51042522-7220788D-5FB5-4C5A-9615-06700E7ACCD1Q56812271-A51B0810-5FAE-4523-9675-78E18297844BQ58800074-FF0C6C32-8194-4BEB-BD88-1BB0443A04AF
P2860
Increasing oral absorption of polar neuraminidase inhibitors: a prodrug transporter approach applied to oseltamivir analogue.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Increasing oral absorption of ...... plied to oseltamivir analogue.
@en
Increasing oral absorption of ...... plied to oseltamivir analogue.
@nl
type
label
Increasing oral absorption of ...... plied to oseltamivir analogue.
@en
Increasing oral absorption of ...... plied to oseltamivir analogue.
@nl
prefLabel
Increasing oral absorption of ...... plied to oseltamivir analogue.
@en
Increasing oral absorption of ...... plied to oseltamivir analogue.
@nl
P2093
P2860
P356
P1476
Increasing oral absorption of ...... plied to oseltamivir analogue.
@en
P2093
Arik Dahan
Deepak Gupta
Gordon L Amidon
John Hilfinger
Kyung-Dall Lee
Sheeba Varghese Gupta
Yasuhiro Tsume
P2860
P304
P356
10.1021/MP300564V
P407
P577
2013-01-04T00:00:00Z